HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Targeted expression of BikDD eliminates breast cancer with virtually no toxicity in noninvasive imaging models.

Abstract
Breast cancer is a major public health problem all over the world, and the current treatment strategies are not potent enough for some patients, especially those with triple-negative breast cancer. Therefore, novel and more effective treatments are critically needed. Of the current methods, targeted therapy, which not only retains cancer-specific expression but also limits toxicity, is a new strategy for treating cancers. In this study, we found that the human telomerase reverse transcriptase (hTERT; T) promoter also possesses high target specificity in breast cancer. Moreover, we developed a versatile T-based breast cancer-specific promoter VISA (VP16-Gal4-WPRE integrated systemic amplifier) composite (T-VISA) to target transgene expression in breast tumors, which has stronger activity comparable or higher than that of the cytomegalovirus promoter in cancer cells. Thereafter, targeted expression of BikDD (a mutant form of proapoptotic gene Bik) through the T-VISA platform in breast cancer initiated robust antitumor effects and prolonged survival in multiple xenograft and syngeneic orthotopic mouse models of breast tumors with virtually no toxicity in intact mice. Thus, these findings show that our T-VISA-BikDD nanoparticles effectively and safely eradicate breast cancer in vitro and in vivo and are worthy of development in clinical trials treating breast cancer.
AuthorsXinhua Xie, Laisheng Li, Xiangsheng Xiao, Jiaoli Guo, Yanan Kong, Minqing Wu, Wanli Liu, Guoquan Gao, Jennifer L Hsu, Weidong Wei, Mien-Chie Hung, Xiaoming Xie
JournalMolecular cancer therapeutics (Mol Cancer Ther) Vol. 11 Issue 9 Pg. 1915-24 (Sep 2012) ISSN: 1538-8514 [Electronic] United States
PMID22752427 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright©2012 AACR.
Chemical References
  • Apoptosis Regulatory Proteins
  • BIK protein, human
  • Membrane Proteins
  • Mitochondrial Proteins
  • Luciferases, Firefly
  • TERT protein, human
  • Telomerase
Topics
  • Animals
  • Apoptosis
  • Apoptosis Regulatory Proteins (biosynthesis, genetics)
  • Breast Neoplasms (pathology, therapy)
  • Cell Line, Tumor
  • Cell Proliferation
  • Female
  • Gene Expression
  • Gene Transfer Techniques
  • Genes, Reporter
  • Genetic Therapy
  • Humans
  • Luciferases, Firefly (biosynthesis, genetics)
  • Membrane Proteins (biosynthesis, genetics)
  • Mice
  • Mice, Inbred BALB C
  • Mice, Nude
  • Mitochondrial Proteins
  • Nanoparticles (chemistry)
  • Neoplasm Transplantation
  • Promoter Regions, Genetic
  • Telomerase (genetics)
  • Transgenes
  • Tumor Burden

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: